Kenya to roll out HIV prevention shots in March
Kenya will roll out a groundbreaking new HIV-prevention drug in March across 15 priority regions, the health ministry said on Wednesday.
Feb 18, 2026
0
11
HIV & AIDS news
HIV entry blocker pairs CD4 mimic and antibody, showing sevenfold higher efficacy
Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting the gp120 on the viral ...
Feb 17, 2026
0
20
The economic cost of HIV: New study quantifies impact on work and income
Utilizing data from Stichting HIV monitoring (SHM) and Statistics Netherlands, a study published in the journal Nature Communications has compared labor market outcomes of 5,960 people diagnosed with HIV between 2010 and ...
Feb 16, 2026
1
8
Human stem cell lines offer new resource to help study HIV progression
King's College London researchers have created a unique collection of human stem cell models that could help to uncover why HIV leads to different outcomes in different people. The research was carried out by Dr. Nathalia ...
Feb 13, 2026
0
8
States sue to block $600 million cut to public health funds
Four states are suing to stop the Trump administration from rescinding hundreds of millions of dollars already set aside for public health programs.
Feb 13, 2026
1
6
HIV antibody opens up new approaches for vaccine development and combination therapies
An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. This study, led by Professor Dr. Florian ...
Feb 12, 2026
0
25
Gut microbes bolster immunity in HIV patients, research reveals
The circumstances surrounding a study on a deadly virus could hardly have been more dramatic. One of its first authors was forced to flee his homeland when it became a war zone. More than 2,000 kilometers away, the laboratory ...
Feb 12, 2026
0
18
First of its kind daily HIV treatment shows promising results
Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for the potential of widespread ...
Feb 9, 2026
0
18
Early TB treatment cuts HIV-related sepsis deaths by 23%, trial finds
Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and causes organs to fail. Africa bears the world's highest burden of sepsis, with an estimated 48 million ...
Feb 7, 2026
0
9
How 'invisible' vaccine scaffolding boosts HIV immune response
One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein scaffolding that mimics ...
Feb 5, 2026
0
17
